Jan Anders Vedin
Director/Board Member at IRLAB THERAPEUTICS AB
Jan Anders Vedin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IRLAB THERAPEUTICS AB | Director/Board Member | 19/02/2023 | - |
| Chairman | 31/12/2015 | 19/02/2023 | |
| Independent Dir/Board Member | 31/12/2015 | - | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Corporate Officer/Principal | - | - |
| Chalmers University of Technology | Corporate Officer/Principal | 01/09/2009 | - |
Göteborgs Stadsteater AB
 Göteborgs Stadsteater AB Movies/EntertainmentConsumer Services Göteborgs Stadsteater AB engages in the operation of theater at Götaplatsen and at Backa Theater. It offers rehearsal studios, props, painting, wardrobe, scenery, and mask and wig departments. The company was founded in 1918 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - | - |
Career history of Jan Anders Vedin
Former positions of Jan Anders Vedin
| Companies | Position | Start | End |
|---|---|---|---|
Resistentia Pharmaceuticals AB
 Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Resistentia Pharmaceutical's business strategy is to develop and commercialize immunotherapy as a second generation therapy to monoclonal antibodies for the treatment of chronic diseases. Resistentia’s most advanced program is an immunotherapy against allergy/asthma – a growing health problem with a large unmet medical need. In contrast to existing therapies, which are largely symptomatic, Resistentia’s novel immunotherapeutic approach targets the cause of the allergic reactions, rather than the symptoms. In addition, Resistentia is developing an immunotherapy for the treatment of rheumatoid arthritis. The project is currently in discovery phase. | Chairman | 31/12/1999 | 23/06/2010 |
| MEDIVIR AB | Chairman | - | 28/04/2010 |
Recepticon ApS
 Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Chairman | - | 22/03/2010 |
Biacore International AB
 Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Director/Board Member | - | 14/08/2006 |
| Astra Hässle AB | Chief Executive Officer | 31/12/1984 | 01/01/1988 |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ | - | - | |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Jan Anders Vedin
| University of Gothenburg | Doctorate Degree |
Statistics
International
| Sweden | 17 |
| Denmark | 2 |
| Norway | 2 |
Operational
| Director/Board Member | 8 |
| Chairman | 8 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 4 |
| Commercial Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| MEDIVIR AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
| IRLAB THERAPEUTICS AB | Health Technology |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Private companies | 13 |
|---|---|
Biacore International AB
Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Health Technology |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Resistentia Pharmaceutical's business strategy is to develop and commercialize immunotherapy as a second generation therapy to monoclonal antibodies for the treatment of chronic diseases. Resistentia’s most advanced program is an immunotherapy against allergy/asthma – a growing health problem with a large unmet medical need. In contrast to existing therapies, which are largely symptomatic, Resistentia’s novel immunotherapeutic approach targets the cause of the allergic reactions, rather than the symptoms. In addition, Resistentia is developing an immunotherapy for the treatment of rheumatoid arthritis. The project is currently in discovery phase. | Health Technology |
Recepticon ApS
Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Health Technology |
Sana Pharma Medical AS
 Sana Pharma Medical AS Pharmaceuticals: MajorHealth Technology Sana Pharma Medical AS develops topical analgesic products. It develops products against various chronic pain conditions, including osteoarthritis of the knee. Its product 2PX provides clinical benefit in the management of both nociceptive and neuropathic pain. The company was founded in 2002 and is headquartered in Oslo, Norway. | Health Technology |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Health Technology |
Cewatech AB
 Cewatech AB BiotechnologyHealth Technology Cewatech AB engages in the development of a sustainable fish feed ingredient that can be an alternative to fish meal. It develops a technology based on the cultivation of microscopic fungi on waste products of plant breeding processes. The company was founded by Anders Felix Edebo in 1993 and is headquartered in Gothenburg, Sweden. | Health Technology |
| Astra Hässle AB | |
Cobalt Astra, Inc.
 Cobalt Astra, Inc. Personnel ServicesCommercial Services Cobalt Astra, Inc. provides outsourced human resources and payroll management services. The firm’s services include human resources, employee benefits, risk management, government compliance and book keeping. The company was founded by Shane Jones in 1999 and is headquartered in Mission, KS. | Commercial Services |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Commercial Services |
Göteborgs Stadsteater AB
Göteborgs Stadsteater AB Movies/EntertainmentConsumer Services Göteborgs Stadsteater AB engages in the operation of theater at Götaplatsen and at Backa Theater. It offers rehearsal studios, props, painting, wardrobe, scenery, and mask and wig departments. The company was founded in 1918 and is headquartered in Gothenburg, Sweden. | Consumer Services |
- Stock Market
- Insiders
- Jan Anders Vedin
- Experience
